ArticleCancers2024
Dual Checkpoint Aptamer Immunotherapy: Unveiling Tailored Cancer Treatment Targeting CTLA-4 and NKG2A.
Mohamad Ammar Ayass et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ArticleCancers2024
Mohamad Ammar Ayass et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.